Halbert Hargrove Global Advisors’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
Other funds holding ALNY
Halbert Hargrove Global Advisors's ALNY Position: Q2 2026 in Review
Halbert Hargrove Global Advisors opened a new position in Alnylam Pharmaceuticals (ALNY) in Q2 2026: 1 share worth $320. The stake represents ﹤0.01% of the portfolio and ranks #592 among its holdings. This is a return to the name: Halbert Hargrove Global Advisors previously reported a position in ALNY as recently as Q3 2025.
Halbert Hargrove Global Advisors first reported a position in ALNY in Q1 2025 and has held it in 3 quarters since. The position peaked at $10.5K in Q3 2025. 790 funds tracked by Wall St. Rank hold ALNY as of Q2 2026.
- Halbert Hargrove Global Advisors held 1 share of Alnylam Pharmaceuticals worth $320 as of Q2 2026.
- Alnylam Pharmaceuticals was a new Halbert Hargrove Global Advisors position in Q2 2026.
- Alnylam Pharmaceuticals made up ﹤0.01% of Halbert Hargrove Global Advisors's portfolio in Q2 2026, its #592 holding.
- Halbert Hargrove Global Advisors first reported a position in Alnylam Pharmaceuticals in Q1 2025 and has held it in 3 quarters since.
- Halbert Hargrove Global Advisors's Alnylam Pharmaceuticals position peaked at $10.5K in Q3 2025.
- 790 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q2 2026.
Based on Halbert Hargrove Global Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.